cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nevro Corp
1 own
2 watching
Current Price
$36.45
$-1.43
(-3.78%)
logo-nvro
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,291.23M
52-Week High
52-Week High
78.9
52-Week Low
52-Week Low
34.7
Average Volume
Average Volume
0.86M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,291.23M
icon52-Week High78.9
icon52-Week Low34.7
iconAverage Volume0.86M
iconDividend Yield--
iconP/E Ratio--
What does the Nevro Corp do?
Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.
Read More
How much money does Nevro Corp make?
News & Events about Nevro Corp.
PR Newswire
7days ago
Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results PR Newswire REDWOOD CITY, Calif., Jan. 19, 2023 Company to Host Conference Call on Thursday, February 16, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif...
Ticker Report
1month ago
Canaccord Genuity Group upgraded shares of Nevro (NYSE:NVRO Get Rating) from a hold rating to a buy rating in a research note released on Tuesday, MarketBeat reports. Canaccord Genuity Group currently has $67.00 price objective on the medical equipment providers stock, up from their ...
Zolmax
1month ago
Nevro (NYSE:NVRO Get Rating) had its price target decreased by Truist Financial from $45.00 to $41.00 in a research report released on Tuesday, Benzinga reports. Truist Financial currently has a hold rating on the medical equipment providers stock. Other equities analysts have also recently issued ...
Ticker Report
3 months ago
Shares of Nevro Corp. (NYSE:NVRO Get Rating) have been assigned an average rating of Hold from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, five have assigned a hold ...
PR Newswire
3 months ago
Nevro Comments on UnitedHealthcare Medical Coverage Policy Update Nevro Comments on UnitedHealthcare Medical Coverage Policy Update PR Newswire REDWOOD CITY, Calif., Oct. 10, 2022 REDWOOD CITY, Calif., Oct. 10, 2022 /PRNewswire/ --Nevro Corp.(NYSE: NVRO), a global medical device company that is...
Frequently Asked Questions
Frequently Asked Questions
What is Nevro Corp share price today?
plus_minus_icon
Can Indians buy Nevro Corp shares?
plus_minus_icon
How can I buy Nevro Corp shares from India?
plus_minus_icon
Can Fractional shares of Nevro Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Nevro Corp stocks?
plus_minus_icon
What is today’s traded volume of Nevro Corp?
plus_minus_icon
What is today’s market capitalisation of Nevro Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Nevro Corp?
plus_minus_icon
What percentage is Nevro Corp down from its 52-Week High?
plus_minus_icon
What percentage is Nevro Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$36.45
$-1.43
(-3.78%)
logo-nvro
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00